Abstract: An apparatus for detecting an amount of liquid nitrogen, has a table for supporting a Dewar vessel in which liquid nitrogen used for cooling a semiconductor radio detector is contained. A motion conversion mechanism is engaged with the table for converting the movement of the table in the up and down direction in response to changes in the weight of the liquid nitrogen in the vessel and amplifying and movement. The motion conversion mechanism includes a disk rotated by the amplified motion of the table, and a plurality of sensors adjacent the disk for detecting the rotational position of the disk which is representative of the weight of the liquid nitrogen in the vessel.

Abstract: An automatic steel analysis apparatus for analyzing the composition of steel materials by carrying out an element analysis using an X-ray excited energy dispersion type fluorescent analysis in the conveying path of the steel materials. A movable housing is vertically movably mounted below the conveying path and has a window in the top thereof closed by an X-ray permeable membrane. An X-ray tube and a semiconductor detection element are housed in the movable housing, and the detection element is connected to a computing apparatus for supplying analysis information thereto for enabling the computing apparatus to determine the composition of steel materials. An air conditioning apparatus controls the temperature and humidity within the movable housing.

Abstract: A compound is disclosed which has the formula, ##STR1## where R.sup.1 is a hydrogen atom, or a straight or branched chain alkyl group having 1 to 4 carbon atoms, and R.sup.2 is a straight or branched chain alkyl group having 1 to 4 carbon atoms, ##STR2## in which n is an integer of 0 to 3, or a pharmaceutically acceptable salt thereof. A process for producing the compound and a medicine containing the compound are also disclosed. Such medicine is effectively useful for inhibiting myocardial infarction.

Abstract: A compound is disclosed which has the formula, ##STR1## where R.sup.1 is a hydrogen atom, or a straight or branched chain alkyl group having 1 to 4 carbon atoms, and R.sup.2 is a straight or branched chain alkyl group having 1 to 4 carbon atoms, ##STR2## in which n is an integer of 0 to 3, or a pharmaceutically acceptable salt thereof. A process for producing the compound and a medicine containing the compound are also disclosed. Such medicine is effectively useful for inhibiting myocardial infarction.